BioCentury
ARTICLE | Financial News

Myriad files for follow-on

March 3, 2000 8:00 AM UTC

MYGN hopes to sell 2 million shares underwritten by Morgan Stanley Dean Witter; and CIBC World Markets. The offering includes an overallotment of up to 300,000 shares. The company develops therapeutic...